Fol. Biol. 2002, 48, 114-119
https://doi.org/10.14712/fb2002048030114
Tumour-Inhibitory Effects of Dendritic Cells Administered at the Site of HPV 16-Induced Neoplasms
References
1. , J. (1999a) Dendritic cell-based cancer vaccines. Folia Biol. (Praha) 45, 71-74.
2. , J. (1999b) Granulocyte-macrophage colony- stimulating factor gene-modified vaccines for immunotherapy of cancer. Folia Biol. (Praha) 45, 115-119.
3. , J. (2001) Genetically modified dendritic cell-based cancer vaccines. Folia Biol. (Praha) 47, 153-155.
4. , J. (2002) Animal models for development of thera- peutic HPV16 vaccines (Review). Int. J. Oncol. 20, 207-212.
5. , J., Šímová, J., Hájková, R., Sobota, V., Jandlová, T., Šmahel, M., Sobotková, E., Vonka, V. (1999) Interleukin 2 gene therapy of residual disease in mice carrying tumour induced by HPV 16. Int. J. Oncol. 14, 593-597.
6. , R., Indrová, M., Jandlová, T., Bubeník, J., Reiniš, M. (1999) Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors. Folia Biol. (Praha) 45, 227-231.
7. , H., Melchers, F. (1998) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, 3, 4 or 5 using modified cDNA expression vectors. Eur. J. Immunol. 18, 97-104.
<https://doi.org/10.1002/eji.1830180115>
8. , L., Indrová, M., Hájková, R., Reiniš, M., Šmahel, M., Vonka, V., Bubeník, J., Jandlová, T. (2000) Peritumoral administration of antigen-unstimulated bone marrow- derived dendritic cells inhibits tumour growth. Folia Biol. (Praha) 46, 91-97.
9. , P., Bubeník, J., Sobota, V., Indrová, M., Hájková, R., Mendoza, L., Jandlová, T., Šímová, J. (1999) Granulocyte- macrophage colony-stimulating factor-producing tumour vaccines. Folia Biol. (Praha) 45, 173-177.
10. , Z., Reznikoff, G., Dranoff, G., Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730.
<https://doi.org/10.4049/jimmunol.158.6.2723>
11. , J., Reiniš, M., Sobota, V., Čapková, J., Bubeník, J., Jandlová, T. (2000) Irradiation of geneticaly modified plas- macytoma vaccines results in upregulation of CD80 mole- cule expression, IL-2 production and higher therapeutic efficacy of the vaccines. Folia Biol. (Praha) 46, 11-16.
12. , M., Sobotková, E., Bubeník, J., Žák, R., Ludvíková, V., Hájková, R., Kovařík, J., Jelínek, F., Povýšil, C., Marinov, J., Vonka, V. (2001) Metastatic MHC class I-negative mouse cells derived by transformation with human papil- Vol. 48 Tumour-Inhibitory Effects of Dendritic Cells 119 lomavirus type 16. Br. J. Cancer 84, 374-380.
<https://doi.org/10.1054/bjoc.2000.1615>
